Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07844252
NA

A Novel Multi-functional Artificial Intelligence System on Treatment Efficacy and Implementation in Colonoscopy

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

To overcome non-neoplastic polyp (NNP) resections, computer-aided diagnosis (CADx) systems have been developed. In a meta-analysis, the performance of CADx systems was superior to endoscopists. The proportion of incorrect predictions could be significantly reduced with CADx assistance. It was reported that autonomous AI prediction could achieve an agreement with the standard pathology-based surveillance intervals. In a prospective study targeting diminutive rectosigmoid polyps, CADx achieved a negative predictive value compared to the histology as gold standard. Lesions were amendable for a leave-in-situ strategy, suggesting a potential to reduce the burden of unnecessary polypectomies. It was estimated that the average colonoscopy cost and annual reimbursement could be reduced under the 'diagnose-and-leave' strategy. Nevertheless, almost all existing literature reporting the efficacy of CADx were simulated studies and focused on the diagnostic accuracy (i.e. all polyps were ultimately resected for histopathology). There is a lack of real-world data with hard clinical endpoints to support its implementation. A recent RCT compared leave-in-situ and resect-all strategy with real-time CADx in both arms. Using ADR as the surrogate marker, it was shown that the leave-in-situ strategy with CADx support was non-inferior. The major limitations of this RCT were that: i) CADx were activated in both arms - the pure CADx effect could not be demonstrated; ii) 'resect-all' strategy was not a real-world practice especially for diminutive rectosigmoid polyps; iii) the interaction and decision making between AI and human was not documented and uncertain. A well-designed RCT is warranted to evaluate the pure CADx effect on reducing NNP resections (enhance treatment efficacy) while maintaining the benchmark of ADR (safe implementation). In addition, AI-measured metrics may objectively validate the procedural quality for performance tracking and auditing purposes. If the above points are proven, AI-assisted colonoscopy would become the 'mainstream' in CRC prevention.

Official title: A Novel Multi-functional Artificial Intelligence System on Treatment Efficacy and Implementation in Colonoscopy: an International Multicenter Randomized Controlled Trial

Key Details

Gender

All

Age Range

45 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

2818

Start Date

2026-10-30

Completion Date

2029-09-30

Last Updated

2026-09-28

Healthy Volunteers

Yes

Interventions

DEVICE

CADe/CADx

A novel all-in-one AI system for colonoscopy (GI Genius™ ColonPro™, version 4.0.0, Medtronic plc, Minneapolis, United States) is developed as a pre-installed software in a plug-in device which is compatible with all existing endoscopes and processors.